Ethosuximide May Improve Seizures, EEG, And Behavior
This study looked at adding ethosuximide, a seizure medicine, to treatment for children with developmental and epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS).
This study looked at adding ethosuximide, a seizure medicine, to treatment for children with developmental and epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS).
This study followed 35 children and adolescents with epilepsy who started levetiracetam, a common seizure medicine.
This article discusses a proposed way to personalize dosing of perampanel, a seizure medicine used in drug-resistant epilepsy.
This study looked at whether putting in stereoelectroencephalography (SEEG) depth electrodes might temporarily change how often seizures happen, even though the electrodes are used for testing rather than treatment.
This study developed and tested a computer model called EffiFormer to detect epileptic seizures from EEG recordings.
Researchers looked at how long it took children with drug-resistant epilepsy to get a presurgical epilepsy evaluation after they were recognized as having drug-resistant epilepsy.
This paper is a review, not a new experiment.
This study looked at whether fracture risk differed between two seizure medicines, lacosamide and levetiracetam, when each was used alone in adults with epilepsy.
This report describes one infant with global developmental delay and refractory epilepsy associated with a TBC1D24 mutation.